Steven D. Hollon
Gertrude Conaway Vanderbilt Professor of Psychology
Professor of Psychology and Human Development
Professor of Psychiatry
Hollon's primary interest lies in the etiology and treatment of depression in adults. His work extends from basic psychopathology to prevention and treatment. He is particularly interested in the relative contribution of cognitive and biological processes to depression, and how the relative efficacies of psychosocial versus pharmacological interventions compare. A current interest is the prevention of depression, both with respect to its initial onset and subsequent recurrence following successful treatment.
DeRubeis, R. J., Zajecka, J., Shelton, R. C., Amsterdam, J. D., Fawcett, J., Xu, C., Young, P. R., Gallop, R., & Hollon, S. D. (2020). Prevention of recurrence after recovery from a major depressive episode with antidepressant medication alone or in combination with cognitive behavior therapy: Phase 2 of a 2-phase randomized clinical trial. JAMA Psychiatry, 77(3), 237-245. http://doi:10.1001/ jamapsychiatry.2019.3900
Hollon, S. D., Cohen, Z. D., Singla, D. R., & Andrews, P. W. (2019). Recent developments in the treatment of depression. Behavior Therapy, 50(2), 257-269.
Hollon, S. D., & Teachman, B. A. (2019). Advantages of developing clinical practice guidelines using international standards. Psychotherapy, 56(3), 340-346.
Patel, V., Weobong, B., Weiss, H. A., Anand, A., Bhat, B., Katti, B., Dimidjian, S., Araya, R., Hollon, S. D., King, M., Vijayakumar, L., Park, A. L., McDaid, D., Wilson, G. T., Velleman, R., Kirkwood,B. R., & Fairburn, C. G. (2017). A controlled trial of the effectiveness and cost-effectiveness of the healthy activity program, a lay counsellor delivered brief psychological intervention for severe depression in primary care in India. Lancet, 389(10065), 176-185.
Brent, D.A., Brunwasser, S.M., Hollon, S.D., Weersing, V.R., Clarke, G.N., Dickerson, J.F., Beardslee, W.R., Gladstone, T.R., Porta, G., Lynch, F.L., Iyengar, S., & Garber, J. (2015). Prevention of depression in at-risk adolescents: Impact of a cognitive behavioral prevention program on depressive episodes, depression-free days, and developmental competence 6 years after the intervention. JAMA Psychiatry, 72(11), 1110-1118.
Fournier, J. C., DeRubeis, R. J., Amsterdam, J. A., Shelton, R. C., & Hollon, S. D. (2015). Gains in employment status following antidepressant medication or cognitive therapy for depression. British Journal of Psychiatry, 206, 332-338.
Hollon, S. D., Areán, P. A., Craske, M. G., Crawford, K. A., Kivlahan, D. R., Magnavita, J. J., Ollendick, T. H., Sexton, T. L., Spring, B., Bufka, L. F., Galper, D. G., & Kurtzman, H. (2014). Development of clinical practice guidelines. Annual Review of Clinical Psychology, 10, 213-241.
Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, R. C., Zajecka, J., Young, P. R., Gallop, R. (2014). Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 71(10), 1157-1164.
Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M., & Andersson, G. (2013). Does cognitive behavior therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? BMJ Open, 3(4).